S. Gundersen

3.4k total citations
59 papers, 886 citations indexed

About

S. Gundersen is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, S. Gundersen has authored 59 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 15 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in S. Gundersen's work include Cancer Treatment and Pharmacology (15 papers), Estrogen and related hormone effects (11 papers) and Breast Cancer Treatment Studies (10 papers). S. Gundersen is often cited by papers focused on Cancer Treatment and Pharmacology (15 papers), Estrogen and related hormone effects (11 papers) and Breast Cancer Treatment Studies (10 papers). S. Gundersen collaborates with scholars based in Norway, Belgium and Netherlands. S. Gundersen's co-authors include Einar Hannisdal, Herman Høst, Stener Kvinnsland, Eiliv Lund, J. Renard, Wenche Reed, Jahn M. Nesland, Herbert M. Pinedo, M. Clavel and Knut Lote and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer and British Journal of Cancer.

In The Last Decade

S. Gundersen

55 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Gundersen Norway 17 470 268 246 232 116 59 886
T. Hakes United States 11 880 1.9× 300 1.1× 125 0.5× 152 0.7× 153 1.3× 18 1.4k
Albert A. Keshgegian United States 17 307 0.7× 212 0.8× 464 1.9× 92 0.4× 129 1.1× 39 914
Clarence B. Vaughn United States 15 349 0.7× 236 0.9× 118 0.5× 80 0.3× 128 1.1× 39 669
P. Dodion Belgium 20 446 0.9× 106 0.4× 484 2.0× 70 0.3× 204 1.8× 72 1.1k
Takeo Fujii United States 17 509 1.1× 327 1.2× 301 1.2× 78 0.3× 266 2.3× 76 1.3k
Michael A. Levesque Canada 19 407 0.9× 220 0.8× 405 1.6× 108 0.5× 336 2.9× 32 1.2k
Mariantonietta Colozza Italy 19 1.0k 2.2× 472 1.8× 360 1.5× 101 0.4× 304 2.6× 36 1.4k
Yukihiro Koike Japan 14 251 0.5× 189 0.7× 123 0.5× 57 0.2× 256 2.2× 31 2.2k
Jeong Kim South Korea 17 335 0.7× 120 0.4× 301 1.2× 121 0.5× 208 1.8× 56 1.2k
T Nishihira Japan 22 570 1.2× 200 0.7× 727 3.0× 99 0.4× 492 4.2× 92 1.7k

Countries citing papers authored by S. Gundersen

Since Specialization
Citations

This map shows the geographic impact of S. Gundersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Gundersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Gundersen more than expected).

Fields of papers citing papers by S. Gundersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Gundersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Gundersen. The network helps show where S. Gundersen may publish in the future.

Co-authorship network of co-authors of S. Gundersen

This figure shows the co-authorship network connecting the top 25 collaborators of S. Gundersen. A scholar is included among the top collaborators of S. Gundersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Gundersen. S. Gundersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gundersen, S., et al.. (2025). Gender dynamics in drug-using contexts: Implication for treatment and support. Nordic Studies on Alcohol and Drugs. 42(3). 204–209.
2.
3.
Gundersen, S., Knut Lote, & Kjell Watne. (1998). A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas. European Journal of Cancer. 34(10). 1565–1569. 17 indexed citations
4.
Pyrhönen, Seppo, Ritva Valavaara, Hans Modig, et al.. (1997). Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study. British Journal of Cancer. 76(2). 270–277. 80 indexed citations
5.
Lote, Knut, et al.. (1996). Prognosen ved primære svulster i sentralnervesystemet. Tidsskrift for Den Norske Laegeforening. 2 indexed citations
6.
Gundersen, S., Knut Lote, & Einar Hannisdal. (1996). Prognostic Factors for Glioblastoma Multiforme: Development of a prognostic index. Acta Oncologica. 35(sup8). 123–127. 26 indexed citations
7.
Gundersen, S., et al.. (1995). Adjuvant tamoxifen for pre- and postmenopausal women with estrogen receptor positive, node positive breast cancer: A randomized study. Breast Cancer Research and Treatment. 36(1). 49–53. 15 indexed citations
8.
Vermorken, Jan B., S. Gundersen, M. Clavel, et al.. (1993). Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. Annals of Oncology. 4(4). 303–306. 10 indexed citations
9.
Hannisdal, Einar, S. Gundersen, Stein Kvaløy, et al.. (1993). Follow-up of breast cancer patients stage I–II: A baseline strategy. European Journal of Cancer. 29(7). 992–997. 15 indexed citations
10.
Kaasa, Stein, Erik Thorud, Johan Tausjø, et al.. (1991). Phase I/II study of carboplatin and 5-fluorouracil in patients with advanced head and neck carcinoma. European Journal of Cancer and Clinical Oncology. 27(5). 576–579. 5 indexed citations
11.
Gundersen, S., et al.. (1989). Weekly Anthracycline in the Treatment of Advanced Breast Cancer. Acta Oncologica. 28(6). 883–885. 2 indexed citations
12.
Lundgren, Steinar, S. Gundersen, Ragnhild Klepp, et al.. (1989). Megestrol acetate versus aminoglutethimide for metastatic breast cancer. Breast Cancer Research and Treatment. 14(2). 201–206. 48 indexed citations
13.
Gundersen, S., et al.. (1989). Interferon in combination with vinblastine in advanced malignant melanoma. A phase I–II study. Cancer. 64(8). 1617–1619. 13 indexed citations
14.
Ottestad, Lars, et al.. (1989). Colony forming ability of human breast carcinomas: lack of prognostic significance. British Journal of Cancer. 60(2). 216–219. 6 indexed citations
15.
Gundersen, S., P Dombernowsky, F. Cavalli, et al.. (1989). TCNU (LS 2667), a new active drug in the treatment of advanced colorectal cancer. European Journal of Cancer and Clinical Oncology. 25(7). 1095–1097. 7 indexed citations
16.
Stoter, G., Eitan Shiloni, S. Gundersen, et al.. (1989). Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study. Cancer Treatment Reviews. 16. 59–63. 10 indexed citations
17.
Sessa, Cristiana, S. Gundersen, W. ten Bokkel Huinink, J. Renard, & Franco Cavalli. (1988). Phase II Study of Intravenous Menogaril in Patients With Advanced Breast Cancer. JNCI Journal of the National Cancer Institute. 80(13). 1066–1069. 7 indexed citations
18.
Gundersen, S., et al.. (1987). Phase II trial of Menogaril in advanced malignant melanoma. An EORTC trial. European Journal of Cancer and Clinical Oncology. 23(11). 1707–1708. 2 indexed citations
19.
Abele, R, M. Clavel, P. Dodion, et al.. (1987). The EORTC early clinical trials cooperative group experience with 5-aza-2′-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas. European Journal of Cancer and Clinical Oncology. 23(12). 1921–1924. 92 indexed citations
20.
Otterstad, Jan Erik, S. Gundersen, & Norman Anderssen. (1978). Left anterior hemiblock in acute myocardial infarction. Incidence and clinical significance in relation to the presence of bundle branch block and to the absence of intraventricular conduction defects.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 203(6). 529–34. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Hakes Breakdown of academic impact, for papers by Albert A. Keshgegian Breakdown of academic impact, for papers by Clarence B. Vaughn Breakdown of academic impact, for papers by P. Dodion Breakdown of academic impact, for papers by Takeo Fujii Breakdown of academic impact, for papers by Michael A. Levesque Breakdown of academic impact, for papers by Mariantonietta Colozza Breakdown of academic impact, for papers by Yukihiro Koike Breakdown of academic impact, for papers by Jeong Kim Breakdown of academic impact, for papers by T Nishihira
Rankless by CCL
2026